Fund Holdings — Yiheng Capital Management, L.P.

Total Portfolio Value:
$276.11M
Total Bought:
$4.02M
Total Sold:
$500.57M
Net Transaction:
-$496.55M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Noah Holdings LimitedADS(NOAH)6,719,7226,719,7220$63.50M$80.23M29.06%+$16.73M
Bilibili IncADS3,143,6671,918,564-1,225,103$60.08M$41.15M14.90%-$18.92M
New Oriental Education & Technology Group Inc.ADR(EDU)598,080598,0800$28.59M$32.27M11.69%+$3.67M
JD.com, Inc.CL A(JD)564,113787,413+223,300$23.20M$25.70M9.31%+$2.50M
H World Group LimitedADS(HTHT)645,658488,964-156,694$23.90M$16.59M6.01%-$7.31M
Akero Therapeutics Inc359,791299,791-60,000$14.56M$16.00M5.79%+$1.43M
ATRenew Inc.ADS(RERE)3,163,1173,163,1170$9.30M$10.47M3.79%+$1.17M
Inventiva S.A.ADS(IVA)2,644,9262,644,9260$5.66M$8.44M3.06%+$2.78M
ACM Research, Inc.CL A(ACMR)280,201280,2010$6.54M$7.26M2.63%+$717.3K
Viridian Therapeutics, Inc.(VRDN)500,261500,2610$6.74M$6.99M2.53%+$250.1K
Denali Therapeutics Inc.(DNLI)469,981469,9810$6.39M$6.58M2.38%+$185.6K
DBV Technologies S.A.ADS(DBVT)656,309656,3090$4.48M$6.01M2.18%+$1.54M
Kymera Therapeutics, Inc.(KYMR)122,605122,6050$3.36M$5.35M1.94%+$1.99M
Silvaco Group, Inc.(SVCO)101,233,2001,096,282-100,136,918$461.62M$5.17M1.87%-$456.45M
TAL Education GroupADS(TAL)309,240309,2400$4.09M$3.16M1.14%-$924.6K
Agora, Inc.ADS(API)192,580533,547+340,967$774.2K$2.03M0.74%+$1.26M
Beam Therapeutics Inc.(BEAM)69,05869,0580$1.35M$1.17M0.43%-$174.0K
Yatsen Holding LimitedADS(YSG)96,32896,3280$463.3K$928.6K0.34%+$465.3K
Generation Bio Co191,5301,055,269+863,739$77.6K$337.8K0.12%+$260.2K
Tuniu CorporationADS(TOUR)314,437314,4370$345.9K$264.8K0.10%-$81.1K
Roblox CorporationCL A(RBLX)282,3380-282,338$16.46M$0—-$16.46M
Page 1 of 1
Yiheng Capital Management, L.P. — 13F Holdings — Q2 2025 | TickerTrail